AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.250

-0.010-3.85%

Volume:1.39M

Turnover:357.74K

Market Cap:150.10M

PE:-5.03

High:0.270

Open:0.270

Low:0.250

Close:0.260

52wk High:0.665

52wk Low:0.157

Shares:600.40M

Float Shares:467.70M

Volume Ratio:1.19

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.050

EPS(LYR):-0.050

ROE:-594.54%

ROA:-29.36%

PB:-10.17

PE(LYR):-5.03

Loading ...

Overview Company News Filings

Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%

MT Newswires Live

Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility

THOMSON REUTERS

Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements

THOMSON REUTERS

Dimerix Posts Loss for Year Attributable of A$29.8 Million

Dimerix Ltd - Loss for the Year Attributable A$29.8 Mln

THOMSON REUTERS

Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%

MT Newswires Live

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

MT Newswires Live

Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652

THOMSON REUTERS

Soekarno-Hatta Set to Welcome Emirates' Giant A380

Dimerix Secures US Patent Regarding Kidney Injury Drug Candidate, Shares Jump 4%

MT Newswires Live

Dimerix Ltd-us Patent Granted for Dimerix New Asset Dmx-652

THOMSON REUTERS

Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics

Dimerix - Buys Dmx-652 for All Indications from Mission Therapeutics

THOMSON REUTERS

Dimerix - to Pay $5 Mln Upfront, up to $287 Mln in Milestones for Dmx-652

THOMSON REUTERS

Dimerix - to Pay 8-10% Royalty on Global Net Sales of Dmx-652

THOMSON REUTERS

Dimerix - Phase 2 Trial Ethics Approval Expected H2 2026, First Patient Dosing H1 2027

THOMSON REUTERS

Mission Therapeutics Divests Mtx652 for Acute Kidney Injury to Dimerix

THOMSON REUTERS

Mission Therapeutics: to Receive up to $292 Mln Plus Double-digit Tiered Royalties from Deal

THOMSON REUTERS

Dimerix Hits 'Major Milestone' With AU$10 Million Financing Package, Euroz Hartleys Says

MT Newswires Live

Australia's Dimerix Rises on Funding Boost and Pipeline Acquisition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/DXB.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.25,"timestamp":1789020720000,"preClose":0.26,"halted":0,"volume":1392741,"delay":0,"changeRate":-0.03846153846153849,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.0497,"marketStatus":"Closed","change":-0.01,"latestTime":"09-10 16:12:00 AEST","open":0.27,"high":0.27,"low":0.25,"amount":357735,"amplitude":0.076923,"askPrice":0.26,"askSize":16250,"bidPrice":0.25,"bidSize":337564,"shortable":3,"etf":0,"ttmEps":-0.0497,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.26,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.192532,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.26,"auctionPrice":0.25,"auctionVolume":127457,"auctionTime":1789020597542,"referencePrice":0.25,"referenceTime":1789036203090,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020597542}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-29.36%","roe":"-594.54%","lyrEps":-0.0497,"volumeRatio":1.192532,"shares":600396776,"dividePrice":0,"high":0.27,"amplitude":0.076923,"preClose":0.26,"low":0.25,"week52Low":0.157,"pbRate":"-10.17","psRate":"23.62","week52High":0.665,"institutionHeld":0,"latestPrice":0.25,"committee":0.908144,"eps":-0.0497,"divideRate":0,"volume":1392741,"delay":0,"ttmEps":-0.0497,"open":0.27,"prevYearClose":0.55,"prevWeekClose":0.285,"prevMonthClose":0.28,"prevQuarterClose":0.205,"fiveDayClose":0.29,"twentyDayClose":0.295,"sixtyDayClose":0.21,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664800459","title":"Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800459","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800459?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482421,"startTime":"0","endTime":"0","summary":"Dimerix  secured non-dilutive loan facility agreements with a syndicate of Australian and US-based lenders to access up to AU$34 million, according to a Friday Australian bourse filing.This included a previously announced initial facility agreement of AU$10 million with Skiptan, per the filing. The firm confirmed that it was funded through to completion of the Action3 phase 3 trial in DMX-200, as well as the planned phase 2 clinical trial in DMX-652.The facility carries an interest rate of 10% per year, compounding annually, the company said. The receipt of the initial 50% draw-down is anticipated by Sept. 18, and the remainder is expected to take place at the firm's discretion on or before March 31, 2027.The facility provides the flexibility for Dimerix to elect to take further commitments for up to a total of AU$50 million on or before March 31, 2027.The biopharmaceutical company's shares were up 4% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802749","title":"Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802749?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:17","pubTimestamp":1788477460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864668","title":"Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864668?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:43","pubTimestamp":1788302639,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662721510","title":"Dimerix Posts Loss for Year Attributable of A$29.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662721510","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662721510?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:49","pubTimestamp":1787795375,"startTime":"0","endTime":"0","summary":"Aug 27 (Reuters) - Dimerix Ltd::*LOSS FOR THE YEAR ATTRIBUTABLE A$29.8 MILLION*REVENUES FROM ORDINARY ACTIVITIES FOR THE YEAR A$7 MILLION*Further company coverage: DXB.AX* ((Reuters.Briefs@thomsonreut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nRSD9nJQBR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662282967","title":"Dimerix Ltd - Loss for the Year Attributable A$29.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662282967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662282967?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:58","pubTimestamp":1787785108,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N17L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340889","title":"Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340889","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340889?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:53","pubTimestamp":1787197984,"startTime":"0","endTime":"0","summary":"Dimerix  received an initial $10 million upfront payment under a license agreement with Everest Medicines, according to a Thursday filing with the Australian bourse.Everest holds exclusive rights to commercialize DMX-200 for the treatment of kidney disease focal segmental glomerulosclerosis across Greater China, South Korea, and Southeast Asia.Dimerix said it is eligible to receive up to an additional $330 million in success-based development, regulatory, and commercial milestone payments, in addition to tiered royalties on net sales of the DMX-200 in the licensed regions.The company's shares gained 4% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","DXB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243106","title":"Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:43","pubTimestamp":1786930994,"startTime":"0","endTime":"0","summary":"Dimerix  said it completed the transfer of the investigational new drug application in the US for its acute kidney injury drug candidate, DMX-652, from Mission Therapeutics, according to a Monday Australian bourse filing.Dimerix plans to advance DMX-652 into a phase 2 clinical trial for acute kidney injury associated with cardiac surgery during the second half, to investigate its potential to prevent kidney injury and preserve renal function.Its shares jumped 6% in recent trading on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660875103","title":"Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2660875103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660875103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:38","pubTimestamp":1786919913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nTUE7JZ8SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655355611","title":"Soekarno-Hatta Set to Welcome Emirates' Giant A380","url":"https://stock-news.laohu8.com/highlight/detail?id=2655355611","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655355611?lang=en_us&edition=fundamental","pubTime":"2026-07-31 12:54","pubTimestamp":1785473684,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Soekarno-Hatta International Airport, operated under InJourney Airports , is set to welcome the inaugural landing of Emirates Airlines' Airbus A380-800, which will operate flight EK358 from Dubai  to Jakarta .Soekarno-Hatta International Airport General Manager Heru Karyadi stated that the world's largest passenger airliner is scheduled to touch down in Jakarta on August 8, 2026, at 10:25 p.m. Jakarta time  before making its return journey to Dubai as flight EK359 on August 9, 2026, at 12:45 a.m. WIB.\"The arrival of the Airbus A380-800 is a major milestone in expanding Indonesia's international air connectivity,\" Heru said on Friday, July 31, 2026.","market":"nz","thumbnail":"https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["DXB.AU","PCR","BK7501","DXB","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653797401","title":"Dimerix Secures US Patent Regarding Kidney Injury Drug Candidate, Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653797401","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653797401?lang=en_us&edition=fundamental","pubTime":"2026-07-23 09:27","pubTimestamp":1784770064,"startTime":"0","endTime":"0","summary":"Dimerix  said the United States Patent and Trademark Office granted a patent providing composition-of-matter-type claims covering the firm's drug candidate, DMX-652, until April 11, 2043, according to a Thursday Australian bourse filing.The candidate is a selective inhibitor of USP30, a mitochondrial enzyme, designed to prevent kidney injury and promote mitophagy where damage has occurred. A divisional application has also been filed to pursue additional claims covering DMX-652, the filing added.Its shares rose 4% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653791917","title":"Dimerix Ltd-us Patent Granted for Dimerix New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2653791917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653791917?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:46","pubTimestamp":1784760416,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUE4PKSZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652407438","title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407438","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652407438?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:02","pubTimestamp":1784286128,"startTime":"0","endTime":"0","summary":"Dimerix acquires Phase 2-ready acute kidney injury drug candidate DMX-652 from Mission TherapeuticsDimerix acquired DMX-652 from Mission Therapeutics for all indications, adding a Phase 2-ready acute ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDLbGlB3s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652740715","title":"Dimerix - Buys Dmx-652 for All Indications from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652740715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652740715?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652152407","title":"Dimerix - to Pay $5 Mln Upfront, up to $287 Mln in Milestones for Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652152407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652152407?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652074884","title":"Dimerix - to Pay 8-10% Royalty on Global Net Sales of Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652074884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652074884?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040713","title":"Dimerix - Phase 2 Trial Ethics Approval Expected H2 2026, First Patient Dosing H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652040713?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652940871","title":"Mission Therapeutics Divests Mtx652 for Acute Kidney Injury to Dimerix","url":"https://stock-news.laohu8.com/highlight/detail?id=2652940871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652940871?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652716408","title":"Mission Therapeutics: to Receive up to $292 Mln Plus Double-digit Tiered Royalties from Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2652716408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652716408?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652064471","title":"Dimerix Hits 'Major Milestone' With AU$10 Million Financing Package, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652064471","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652064471?lang=en_us&edition=fundamental","pubTime":"2026-07-17 12:24","pubTimestamp":1784262255,"startTime":"0","endTime":"0","summary":"Dimerix's (ASX:DXB) AU$10 million financing package represents a \"major milestone\" as the company is now fully funded through the completion of its phase 3 focal segmental glomerulosclerosis study for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476049","title":"Australia's Dimerix Rises on Funding Boost and Pipeline Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652476049?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:38","pubTimestamp":1784255930,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on funding boost and pipeline acquisition** Shares of Australia's DimerixDXB.AXrise as much as 10.4% to A$0.265, their biggest intraday pct gain since July 6** Stock at its highest level since July 7** DXB stock set to mark its second consecutive session of gains, if trend holds** Stock up 2.1% in the week so far** The clinical stage biopharmaceutical firmsecuresa A$10 million  loan facility** Loan facility to support commercial manufacturing of DMX-200, a pill for kidney diseases, ahead of potential marketing approval submission and preparation for commercial launch, among others** Company separately says it expands pipeline with acquisition of DMX-652 for acute kidney injury** Near 4.7 million shares change hands, 1.5x the 30-day average** Stock has fallen 55.5% this year, including session moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}